✦ LIBER ✦

The Study of Tamoxifen and Raloxifene: Preliminary Enrollment Data from a Randomized Breast Cancer Risk Reduction Trial

✍ Scribed by Victor G. Vogel; Joseph P. Costantino; D. Lawrence Wickerham; Walter M. Cronin; Norman Wolmark

Book ID: 119934612
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 126 KB
Volume: 3
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2002.n.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1–57 Effects of Tamoxifen vs Raloxifene

1–57 Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes: The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial

📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 99 KB

Risk-Benefit Profile for Raloxifene: 4-Y

Risk-Benefit Profile for Raloxifene: 4-Year Data From the Multiple Outcomes of Raloxifene Evaluation (MORE) Randomized Trial

✍ Elizabeth Barrett-Connor; Jane A Cauley; Pandurang M Kulkarni; Andreas Sashegyi; 📂 Article 📅 2004 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 90 KB

Who participates in a randomized trial o

Who participates in a randomized trial of mindfulness-based stress reduction (MBSR) after breast cancer? A study of factors associated with enrollment among Danish breast cancer patients

✍ Hanne Würtzen; Susanne Oksbjerg Dalton; Klaus Kaae Andersen; Peter Elsass; Henri 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

Lessons learned from enrollment in the B

Lessons learned from enrollment in the BEST study—A multicenter, randomized trial of group psychosocial support in metastatic breast cancer

✍ Pamela J. Goodwin; Molyn Leszcz; Gail Quirt; Jan Koopmans; Andrew Arnold; Elizab 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 254 KB

The potential risk of neoadjuvant chemot

The potential risk of neoadjuvant chemotherapy in breast cancer patients—results from a prospective randomized trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-07)

✍ Susanne Taucher; Guenther G. Steger; Raimund Jakesz; Christoph Tausch; Viktor We 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 252 KB

Relationships between CYP2D6 phenotype,

Relationships between CYP2D6 phenotype, breast cancer and hot flushes in women at high risk of breast cancer receiving prophylactic tamoxifen: results from the IBIS-I trial

✍ Sestak, I; Kealy, R; Nikoloff, M; Fontecha, M; Forbes, J F; Howell, A; Cuzick, J 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 189 KB